Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke

Annals of Neurology

Volumn 73, Issue 1, 2013, Pages 129-135

  Yigitkanli, Kazim ^a   Pekcec, Anton ^a   Karatas, Hulya ^a   Pallast, Stefanie ^a   Mandeville, Emiri ^a   Joshi, Netra ^b   Smirnova, Natalya ^c   Gazaryan, Irina ^c   Ratan, Rajiv R ^c   Witztum, Joseph L ^d   Montaner, Joan ^e   Holman, Theodore R ^b   Lo, Eng H ^a   Van Leyen, Klaus ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; LIPOXYGENASE INHIBITOR; LOXBLOCK 1; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGED; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; FEMALE; HUMANS; LIPOXYGENASE INHIBITORS; MALE; MICE; MIDDLE AGED; STROKE; TREATMENT OUTCOME;

EID: 84873411666     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23734     Document Type: Article

References (33)

1. California Acute Stroke Pilot Registry (CASPR) Investigators. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology 2005; 64: 654-659.
2. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011; 123: e18-e209.
3. Moskowitz MA, Lo EH, Iadecola C,. The science of stroke: mechanisms in search of treatments. Neuron 2010; 67: 181-198.
4. Niizuma K, Endo H, Chan PH,. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 2009; 109 (suppl 1): 133-138.
5. Saito A, Maier CM, Narasimhan P, et al. Oxidative stress and neuronal death/survival signaling in cerebral ischemia. Mol Neurobiol 2005; 31: 105-116.
6. Hardingham GE, Lipton SA,. Regulation of neuronal oxidative and nitrosative stress by endogenous protective pathways and disease processes. Antioxid Redox Signal 2011; 14: 1421-1424.
7. Jin G, Arai K, Murata Y, et al. Protecting against cerebrovascular injury: contributions of 12/15-lipoxygenase to edema formation after transient focal ischemia. Stroke 2008; 39: 2538-2543.
8. van Leyen K, Kim HY, Lee SR, et al. Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke 2006; 37: 3014-3018.
9. Khanna S, Roy S, Slivka A, et al. Neuroprotective properties of the natural vitamin E alpha-tocotrienol. Stroke 2005; 36: 2258-2264.
10. Cui L, Zhang X, Yang R, et al. Baicalein is neuroprotective in rat MCAO model: role of 12/15-lipoxygenase, mitogen-activated protein kinase and cytosolic phospholipase A2. Pharmacol Biochem Behav 2010; 96: 469-475.
11. Zhou Y, Fang SH, Ye YL, et al. Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats. Acta Pharmacol Sin 2006; 27: 1103-1110.
12. Munsiff AV, Chander PN, Levine S, Stier CT Jr,. The lipoxygenase inhibitor phenidone protects against proteinuria and stroke in stroke-prone spontaneously hypertensive rats. Am J Hypertens 1992; 5: 56-63.
13. Nishi H, Watanabe T, Sakurai H, et al. Effect of MCI-186 on brain edema in rats. Stroke 1989; 20: 1236-1240.
14. Abe K, Yuki S, Kogure K,. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 1988; 19: 480-485.
15. Lapchak PA, Maher P, Schubert D, Zivin JA,. Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes. Neuroscience 2007; 150: 585-591.
16. van Leyen K, Arai K, Jin G, et al. Novel lipoxygenase inhibitors as neuroprotective reagents. J Neurosci Res 2008; 86: 904-909.
17. Smirnova NA, Haskew-Layton RE, Basso M, et al. Development of neh2-luciferase reporter and its application for high throughput screening and real-time monitoring of nrf2 activators. Chem Biol 2011; 18: 752-765.
18. Smirnova NA, Rakhman I, Moroz N, et al. Utilization of an in vivo reporter for high throughput identification of branched small molecule regulators of hypoxic adaptation. Chem Biol 2010; 17: 380-391.
19. Cuadrado E, Rosell A, Colome N, et al. The proteome of human brain after ischemic stroke. J Neuropathol Exp Neurol 2010; 69: 1105-1115.
20. Pallast S, Arai K, Pekcec A, et al. Increased nuclear apoptosis-inducing factor after transient focal ischemia: a 12/15-lipoxygenase-dependent organelle damage pathway. J Cereb Blood Flow Metab 2010; 30: 1157-1167.
21. Foerch C, Arai K, Jin G, et al. Experimental model of warfarin-associated intracerebral hemorrhage. Stroke 2008; 39: 3397-3404.
22. Wang X, Liu J, Zhu H, et al. Effects of neuroglobin overexpression on acute brain injury and long-term outcomes after focal cerebral ischemia. Stroke 2008; 39: 1869-1874.
23. Karatas H, Erdener SE, Gursoy-Ozdemir Y, et al. Thrombotic distal middle cerebral artery occlusion produced by topical FeCl(3) application: a novel model suitable for intravital microscopy and thrombolysis studies. J Cereb Blood Flow Metab 2011; 31: 1452-1460.
24. Garcia-Yebenes I, Sobrado M, Zarruk JG, et al. A mouse model of hemorrhagic transformation by delayed tissue plasminogen activator administration after in situ thromboembolic stroke. Stroke 2011; 42: 196-203.
25. Palinski W, Yla-Herttuala S, Rosenfeld ME, et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 1990; 10: 325-335.
26. Weismann D, Hartvigsen K, Lauer N, et al. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 2011; 478: 76-81.
27. Li Y, Maher P, Schubert D,. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 1997; 19: 453-463.
28. Khanna S, Roy S, Ryu H, et al. Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem 2003; 278: 43508-43515.
29. Wang H, Li J, Follett PL, et al. 12-Lipoxygenase plays a key role in cell death caused by glutathione depletion and arachidonic acid in rat oligodendrocytes. Eur J Neurosci 2004; 20: 2049-2058.
30. Zhang Y, Wang H, Li J, et al. Peroxynitrite-induced neuronal apoptosis is mediated by intracellular zinc release and 12-lipoxygenase activation. J Neurosci 2004; 24: 10616-10627.
31. Pallast S, Arai K, Wang X, et al. 12/15-Lipoxygenase targets neuronal mitochondria under oxidative stress. J Neurochem 2009; 111: 882-889.
32. Seet RC, Lee CY, Chan BP, et al. Oxidative damage in ischemic stroke revealed using multiple biomarkers. Stroke 2011; 42: 2326-2329.
33. Kenyon V, Chorny I, Carvajal WJ, et al. Novel human lipoxygenase inhibitors discovered using virtual screening with homology models. J Med Chem 2006; 49: 1356-1363.